Methodologic Considerations for Small Cohort Studies.
作者信息
Octaria Rany, Rebeiro Peter F, Kainer Marion A
机构信息
Vanderbilt Epidemiology PhD Program, Vanderbilt University Graduate School, Nashville.
Department of Medicine, Division of Infectious Diseases & Division of Epidemiology, Nashville.
出版信息
Clin Infect Dis. 2019 Oct 15;69(9):1644. doi: 10.1093/cid/ciz201.
Abstract
摘要
相似文献
1
Methodologic Considerations for Small Cohort Studies.小队列研究的方法学考量
Clin Infect Dis. 2019 Oct 15;69(9):1644. doi: 10.1093/cid/ciz201.
2
Reply to Octaria, Rebeiro, and Kainer.回复奥卡里亚、雷贝罗和凯纳。
Clin Infect Dis. 2019 Oct 15;69(9):1645. doi: 10.1093/cid/ciz204.
3
[Linezolid in methicillin-resistant staphylococcus aureus infections].
Unfallchirurg. 2002 Aug;105(8):759-60; author reply 760. doi: 10.1007/s00113-002-0472-x.
4
Clinical characteristics of linezolid-resistant Staphylococcus aureus infections.
Am J Med Sci. 2005 Aug;330(2):102-4. doi: 10.1097/00000441-200508000-00007.
5
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.组织穿透性在实现耐甲氧西林金黄色葡萄球菌引起的医院获得性肺炎和复杂性皮肤软组织感染的成功抗菌治疗中的重要性：万古霉素和利奈唑胺。
Curr Med Res Opin. 2010 Mar;26(3):571-88. doi: 10.1185/03007990903512057.
6
Linezolid-Resistant Staphylococcus aureus in Children With Cystic Fibrosis.患有囊性纤维化儿童中的耐利奈唑胺金黄色葡萄球菌
J Pediatric Infect Dis Soc. 2015 Dec;4(4):e163-5. doi: 10.1093/jpids/piv071. Epub 2015 Oct 14.
7
Linezolid resistance in clinical isolates of Staphylococcus aureus.金黄色葡萄球菌临床分离株中的利奈唑胺耐药性。
J Antimicrob Chemother. 2003 Jan;51(1):186-8. doi: 10.1093/jac/dkg104.
8
[Shifts in minimum inhibitory concentration of linezolid to Stapylococcus aureus strains isolated from 2007 to 2009].
Kansenshogaku Zasshi. 2011 Jul;85(4):386-8. doi: 10.11150/kansenshogakuzasshi.85.386.
9
The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin.利奈唑胺用于对万古霉素不耐受或治疗无效的同情用药患者中治疗金黄色葡萄球菌感染的疗效和安全性。
J Antimicrob Chemother. 2002 Dec;50(6):1017-26. doi: 10.1093/jac/dkf215.
10
Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections.利奈唑胺与万古霉素治疗耐甲氧西林金黄色葡萄球菌感染的比较
Clin Infect Dis. 2003 Jan 15;36(2):236-7. doi: 10.1086/345758.
引用本文的文献
1
Mortality difference from vs bloodstream infections.与血流感染相比的死亡率差异。
Access Microbiol. 2023 Feb 27;5(2):acmi000421. doi: 10.1099/acmi.0.000421. eCollection 2023.
本文引用的文献
1
Early Oral Switch to Linezolid for Low-risk Patients With Staphylococcus aureus Bloodstream Infections: A Propensity-matched Cohort Study.早期口服利奈唑胺治疗金黄色葡萄球菌血流感染低危患者：一项倾向性匹配队列研究。
Clin Infect Dis. 2019 Jul 18;69(3):381-387. doi: 10.1093/cid/ciy916.
2
Comparing the performance of propensity score methods in healthcare database studies with rare outcomes.比较倾向评分方法在具有罕见结局的医疗保健数据库研究中的性能。
Stat Med. 2017 May 30;36(12):1946-1963. doi: 10.1002/sim.7250. Epub 2017 Feb 16.
3
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.金黄色葡萄球菌菌血症：一项前瞻性多中心研究中的复发情况及抗生素治疗的影响
Medicine (Baltimore). 2003 Sep;82(5):333-9. doi: 10.1097/01.md.0000091184.93122.09.
4
"Proving the null hypothesis" in clinical trials.在临床试验中“证明原假设”
Control Clin Trials. 1982 Dec;3(4):345-53. doi: 10.1016/0197-2456(82)90024-1.
Zotero 插件